This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Rare Disease Conference 2026 - Rare Disease Summit
March 17-19, 2026
Pre-Conference Workshops on March 16, 2026Sheraton Philadelphia Downtown | Philadelphia, PA

Farrell Simon
Chief Commercial Officer at Trevi Therapeutics, Inc.
Speaker

Profile

Farrell Simon is currently the Chief Commercial Officer for Trevi Therapeutics, a clinical stage biotech company focused on the development and commercialization of a chronic cough therapy across respiratory diseases. He is an experienced general manager who has worked across the lifecycle of development from marketed products to early commercial development assets. Prior to joining Trevi, Farrell spent 10 years at Pfizer in commercial and operations roles. He last served as Chief of Staff to the Group President of Biopharma at Pfizer and was a member of the Biopharma executive leadership team, which managed $38B in revenue. Farrell started his career at Procter & Gamble.

Agenda Sessions

  • Architecting Success – Building a Foundation for Rare Disease Launch Excellence

    9:00am